Daniel Klamer, Phd, Mba Email and Phone Number
Daniel Klamer, Phd, Mba work email
- Valid
- Valid
Daniel Klamer, Phd, Mba personal email
- Valid
Scientific & Commercialization Strategy / Biopharmaceutical Drug Development / New Business OpportunitiesKey expertise includes: pre-clinical, clinical, regulatory, and commercial aspects of drug development; competitive and market analysis; precision medicine; business strategy; due diligence; project and team leadership.* * * * * * * * * * * * * *Bringing science and business together, I drive promising strategies and initiatives for meaningful impact on those with debilitating neurodegenerative and neurodevelopmental disorders.As a neuroscientist with a Ph.D. in Pharmacology, my background includes years of clinical and pre-clinical research, development of preclinical hypotheses into proven concepts, and supervision of other scientists’ promising projects.As a goal-oriented business leader, I have steered key projects from discovery to development, identified new indications to target, analyzed new opportunities for acquisition and partnering, co-founded a startup, and attracted investors.With my combined experiences and skills, I:- Translate scientific ideas into viable commercialization- Break problems apart and create effective solutions- Identify promising opportunities and effectively assess the risks and benefits of potential mergers and partnerships- Build collaborative relationships with external and internal partners- Create and present realistic, executable timelines and plans for strategic projects- Align and engage teams to highest performance and productivity, and inspire them to achieve key goalsIt is a privilege to apply my skills and expertise at Anavex and contribute to new and effective biopharmaceutical treatments for diseases with a high unmet medical need.
Anavex Life Sciences
View- Website:
- anavex.com
- Employees:
- 45
-
Vice President, Business Development And Scientific StrategyAnavex Life SciencesNew York, Ny, Us -
Vice President, Business Development & Scientific StrategyAnavex Life Sciences Jun 2017 - PresentNew York City, Ny, UsCraft the strategic business case (scientific and commercial) for new drug development initiatives, guide the multi-stage commercialization process and lead the sourcing and assessment of new market opportunities, possible acquisitions, and partnerships. Played role in developing the company to its current position, with multiple late-stage assets with the potential to treat several neurodegenerative and neurodevelopmental diseases. A key member of the Management Team.• Repeatedly spearhead process to identify potential diseases and target populations, conduct competitive and market analysis, and guide drug development from pre-clinical proof of concept to commercialization• Assess new, competitive, and potentially synergistic therapeutic compounds or devices• Developed a structured, efficient process and lead detailed due diligence on potential deals• Present at investor and scientific conferences -
Senior Director Of Business DevelopmentAnavex Life Sciences Sep 2015 - May 2017New York City, Ny, UsJoined as 3rd employee, playing a vital role in the company’s initial growth and pipeline development -
Associate Professor (Part-Time Since 2010)Department Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg Apr 2009 - PresentSupervise multiple doctoral and master’s-level pre-clinical and clinical research projects• Developing preclinical hypotheses to clinical proof-of-concept studies• Lead international seminars and successfully obtained major research funding grants
-
Co-FounderCognite Ab Mar 2010 - Dec 2022• Hired and built effective, cross-functional team of experts in business development and marketing, intellectual property law and operations• Attracted critical new investors and partners• Negotiated major investment to commercialize Eidisine™ including significant financing by venture capital
-
Business Development AnalystRetrophin Apr 2014 - Feb 2015Played central role in identifying strategic buying and partnering opportunities within a tight timeframe• Created product and company financial models and scenario assessments, and performed due diligence• Contributed to deal negotiations and execution• Identified and evaluated companies/products for orphan indications in e.g. liver, kidney and CNS• Analyzed the competitive drug landscape from both financial and scientific perspective
-
Senior Scientist & Project LeaderIntellect Neurosciences, Inc. Jan 2013 - Apr 2013Led development of product pipeline and out-licensing. Developed, managed and communicated integrated project plans to partners and CROs.
-
Senior Research ScientistNeurosearch Jun 2010 - Dec 2011Led and evaluated multiple discovery-phase neuropharmacological research products with a focus on strategic evaluation at preclinical and clinical stages for development and commercialization. Managed teams of up to 15 people, from technicians to Ph.D. level. Led key projects for transitioning discovery phase substances into candidate drugs; crafted and sold business case and obtained critical financing for development.
-
Post-Doc/Senior ResearcherDepartment Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg Jan 2007 - Mar 2009Gothenburg, SeInvestigated cognitive impairments in psychiatric diseases. -
Post-DocDepartment Of Psychiatry, Yale University School Of Medicine Aug 2005 - Dec 2006Investigated neuronal synchronization in order to identify cognitive processes.Participated in the course “Learning to mentor a new generation of scientists” and workshops for “Preparing future science faculty”.
-
Research PositionDepartment Of Pharmacology, The Sahlgrenska Academy At University Of Gothenburg Jan 2005 - Aug 2005
Daniel Klamer, Phd, Mba Skills
Daniel Klamer, Phd, Mba Education Details
-
Fordham Gabelli School Of BusinessFinance -
University Of GothenburgPharmacology -
Uc San DiegoDepartment Of Psychiatry
Frequently Asked Questions about Daniel Klamer, Phd, Mba
What company does Daniel Klamer, Phd, Mba work for?
Daniel Klamer, Phd, Mba works for Anavex Life Sciences
What is Daniel Klamer, Phd, Mba's role at the current company?
Daniel Klamer, Phd, Mba's current role is Vice President, Business Development and Scientific Strategy.
What is Daniel Klamer, Phd, Mba's email address?
Daniel Klamer, Phd, Mba's email address is da****@****ail.com
What schools did Daniel Klamer, Phd, Mba attend?
Daniel Klamer, Phd, Mba attended Fordham Gabelli School Of Business, University Of Gothenburg, Uc San Diego.
What are some of Daniel Klamer, Phd, Mba's interests?
Daniel Klamer, Phd, Mba has interest in Martial Arts, Skiing, Interest In Running.
What skills is Daniel Klamer, Phd, Mba known for?
Daniel Klamer, Phd, Mba has skills like Neuroscience, Pharmacology, Biotechnology, Clinical Development, Drug Discovery, Biochemistry, Research, R&d, Lifesciences, Pharmaceutical Industry, Clinical Trials, Start Ups.
Who are Daniel Klamer, Phd, Mba's colleagues?
Daniel Klamer, Phd, Mba's colleagues are Janusz Debowski, James T., Andrew Morris, Alessandro Mammoli, Vanessa Vogel-Farley, Fernando Caday, Clara Silvey.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial